Cranney Ann, O'Connor Annette M, Jacobsen Mary J, Tugwell Peter, Adachi Jonathan D, Ooi Daylily S, Waldegger Lisa, Goldstein Rose, Wells George A
Department of Medicine, Ottawa Hospital, C4-CEU, 1053 Carling Avenue, Ontario, Canada K1Y4-E9.
Patient Educ Couns. 2002 Jul;47(3):245-55. doi: 10.1016/s0738-3991(01)00218-x.
This study's aim was to develop and pilot test an evidence-based decision aid for postmenopausal women with osteoporosis who are considering options to prevent fractures. The aid was based on the Ottawa Decision Support Framework, and integrated evidence from our Cochrane systematic reviews. Following development by a panel of experts in osteoporosis and decision making, a user review panel of practitioners and women who had already made their decision about osteoporosis therapy reviewed the decision aid for acceptability. Then the decision aid was pilot tested using a before-after design in women at the point of decision making. Compared to baseline, there were statistically significant improvements in knowledge, realistic expectations and decreased decisional conflict. Our decision aid shows promise in preparing women for counseling about osteoporosis therapies. Long-term adherence to chosen therapy and quality of life will be evaluated in a randomized controlled trial.
本研究的目的是为考虑预防骨折方案的绝经后骨质疏松症女性开发并进行基于证据的决策辅助工具的试点测试。该辅助工具基于渥太华决策支持框架，并整合了我们Cochrane系统评价的证据。在由骨质疏松症和决策领域的专家小组进行开发之后，一个由已经对骨质疏松症治疗做出决策的从业者和女性组成的用户评审小组对该决策辅助工具的可接受性进行了评审。然后，在决策点使用前后设计对女性进行了该决策辅助工具的试点测试。与基线相比，在知识、现实期望方面有统计学上的显著改善，决策冲突减少。我们的决策辅助工具在帮助女性为骨质疏松症治疗咨询做准备方面显示出前景。将在一项随机对照试验中评估对所选治疗的长期依从性和生活质量。
